Global License Agreement in Hemophilia BGlobal License Agreement • June 24th, 2020
This presentation contains forward-looking statements. All statements other than statements of historical fact are forward-looking statements, which are often indicated by terms such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “goal,” “intend,” “look forward to,” “may,” “plan,” “potential,” “predict,” “project,” “should,” "will,” “would” and similar expressions. Forward-looking statements are based on management's beliefs and assumptions and on information available to management only as of the date of this presentation. These forward- looking statements include, but are not limited to, statements regarding the development of our gene therapies, the success of our collaborations, and the risk of cessation, delay or lack of success of any of our ongoing or planned clinical studies and/or development of our product candidates. Our actual results could differ materially from those anticipated in these forward-looking statements for many reasons, including, without limitatio
GLOBAL LICENSE AGREEMENT by and among PROTHENA BIOSCIENCES LIMITED and CELGENE SWITZERLAND LLC Dated as of July 5, 2023Global License Agreement • November 2nd, 2023 • Prothena Corp Public LTD Co • Pharmaceutical preparations • New York
This GLOBAL LICENSE AGREEMENT (this “Agreement”) is entered into and made effective as of July 5, 2023 (the “Effective Date”) by and between Prothena Biosciences Limited, an Irish limited company (“Prothena”) and Celgene Switzerland LLC, a Delaware limited liability company (“Celgene”). Celgene and Prothena are each referred to herein by name or as a “Party” or, collectively, as the “Parties”.
EPS CHINA DATA GLOBAL LICENSE AGREEMENTGlobal License Agreement • January 10th, 2019
IN CONSIDERATION OF the mutual promises set forth herein and attached hereto, Licensor and Licensee agree to be bound by the terms and conditions. AND THEREFORE IN WITNESS, Licensor and Licensee have caused this Agreement to be executed.
AMENDMENT TO GLOBAL LICENSE AGREEMENTGlobal License Agreement • March 25th, 2024 • Hall of Fame Resort & Entertainment Co • Services-miscellaneous amusement & recreation
THIS AMENDMENT TO GLOBAL LICENSE AGREEMENT (this “Amendment”) is made and entered into as of September 13, 2023, between NATIONAL FOOTBALL MUSEUM, INC., an Ohio non-profit corporation, doing business as Pro Football Hall of Fame (hereinafter “PFHOF”), and HOF VILLAGE NEWCO, LLC, a Delaware limited liability limited partnership (hereinafter “HOFV”), each a “Party” and collectively, the “Parties”.
